Equity · Healthcare
EVH
NYSEEvolent Health, Inc.
$3
−5.36% vs prior close
Finazon · prior-day close, indicative (IEX-derived, not the official close) · Jul 31, 2026
Price · Chart
$6
$2
21 Jul
31 Jul
The line runs $5.85 on 21 July through $3 on 31 July, on a scale from $2 to $6. Days the market did not trade hold the previous close, flat.
Market cap
$339.2M
52-week range
$2.16 – $10.06
Avg volume
628.2K
as of Jul 31, 2026
EVH insider trades
Open-market buys
0
Open-market sells
1
Net sold
$329K
Non-trade filings
0
Date
Insider
Type
Shares
Value
26 Aug 2026
McCarthy Daniel Joseph
PRESIDENT
Sell
65,892
$329K
EVH reported financials
SEC EDGAREVH reported revenue of $1.9B for the fiscal year ended 31 Dec 2025. Net income over the same period was −$534.5M.
Figure
Reported
Period
Revenue
$1.9B
31 Dec 2025
fiscal year
Net income
−$534.5M
31 Dec 2025
fiscal year
Diluted EPS
−$5.07
31 Dec 2025
fiscal year
Total assets
$2.0B
30 Jun 2026
at period end
Total equity
$383.2M
30 Jun 2026
at period end
EVH earnings
Date
Period
EPS
Revenue
30 Jun 2026
Q2 2026
−$0.25
—
31 Mar 2026
Q1 2026
−$0.24
—
31 Dec 2025
FY 2025
−$3.84
—
30 Sep 2025
FY 2025
−$0.24
—
30 Jun 2025
FY 2025
−$0.44
—
31 Mar 2025
Q1 2025
−$0.63
—
no date announced in SEC filings yet
Reported figures & scheduled dates · SEC EDGAR filings
EVH institutional holders
SEC EDGAR10 of the 45 institutional funds we track reported a EVH position for the quarter ended 30 Jun 2026 — a combined $69.6M; the latest of those filings landed 02 Sep 2026.
Fund
Action
Shares
Value
EVH fails-to-deliver
SECOn 29 Sep 2026, 99,962 shares of EVH failed to deliver (about $365K) — the latest of 2 consecutive trading days with recorded fails.
Settlement date
Shares failed
Notional
% of shares out
29 Sep 2026
99,962
$365K
0.088%
28 Sep 2026
100,000
$361K
0.088%
10 Sep 2026
1,792
$7K
0.002%
Sources
- Finazonprior-day close, indicative (IEX-derived, not the official close), some closes dollar-rounded at the source
- TradingViewthe price chart widget, drawn by TradingView from their own data
- SEC EDGARSEC EDGAR XBRL company facts · latest period ended 30 Jun 2026
- SEC EDGARSEC EDGAR 13F filings
- SECSEC fails-to-deliver (CNS) data
- SEC EDGARValuation computed from SEC EDGAR filings